Sustained release of alpha-methylacyl-CoA racemase (AMACR) antibody-conjugated and free doxorubicin from silica nanoparticles for prostate cancer cell growth inhibition.
Journal of biomedical materials research. Part B, Applied biomaterials Mar, 2023 | Pubmed ID: 36314600